Diffusion-Weighed MR of the Thyroid Gland in Graves' Disease. Assessment of Disease Activity and Prediction of Outcome

Academic Radiology

Volumn 17, Issue 6, 2010, Pages 779-783

  Abdel Razek, Ahmed Abdel Khalek ^a   Sadek, Ahmed Galal ^a   Gaballa, Gada ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THIAMAZOLE; THYROTROPIN; THYROXINE;

ADULT; APPARENT DIFFUSION COEFFICIENT; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE ACTIVITY; DISEASE COURSE; ECHO PLANAR IMAGING; FEMALE; GRAVES DISEASE; HUMAN; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; REMISSION; SENSITIVITY AND SPECIFICITY; STAGING; THYROID GLAND EXAMINATION; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ADULT; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GRAVES DISEASE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THYROID GLAND; YOUNG ADULT;

EID: 77951977538     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2010.01.014     Document Type: Article

References (29)

1. Weetman A.P. Graves' disease. N Engl J Med 343 (2004) 1236-1248
2. McIver B., and Morris J.C. The pathogenesis of Graves' disease. Endocrinol Metab Clin North Am 27 (1998) 73-89
3. Franklyn J.A. The management of hyperthyroidism. N Engl J Med 330 (2002) 1731-1738
4. Solomon B., Glinoer D., and Lagasse R. Current trends in the management of Graves' disease. J Clin Endocrinol Metab 70 (2005) 1518-1524
5. Vitti P. Grey scale thyroid ultrasonography in the evaluation of patients with Graves' disease. Eur J Endocrinol 142 (2000) 22-24
6. Baldini M., Orsatti A., Bonfanti M., et al. Relationship between the sonographic appearance of the thyroid and the clinical course and autoimmune activity of Graves' disease. J Clin Ultrasound 33 (2005) 381-385
7. Castagnone D., Rivolta R., Rescalli S., et al. Color Doppler sonography in Graves' disease: value in assessing activity of disease and predicting outcome. AJR Am J Roentgenol 166 (1996) 203-207
8. Nagasaki T., Inaba M., Kumeda Y., et al. Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves' disease. Biomed Pharmacother 61 (2007) 472-476
9. Baldini M., Castagnone D., Rivolta R., et al. Thyroid vascularization by color Doppler ultrasonography in Graves' disease. Changes related to different phases and to the long-term outcome of the disease. Thyroid 7 (1997) 823-828
10. Sponza M., Fabris B., Bertolotto M., et al. Role of Doppler color ultrasonography and flowmetric analysis in the diagnosis and follow-up of Graves' disease. Radiol Med 93 (1997) 405-409
11. Saleh A., Cohnen M., Furst G., et al. Prediction of relapse after antithyroid drug therapy of Graves' disease: value of color Doppler sonography. Exp Clin Endocrinol Diabetes 112 (2004) 510-513
12. Arslan H., Unal O., Algun E., et al. Power Doppler sonography in the diagnosis of Graves' disease. Eur J Ultrasound 11 (2000) 117-122
13. Meller J., and Becker W. The continuing importance of thyroid scintigraphy in the era of high-resolution ultrasound. Eur J Nucl Med 29 Suppl.2 (2002) S425-S438
14. Kabala J.E. Computed tomography and magnetic resonance imaging in diseases of the thyroid and parathyroid. Eur J Radiol 66 (2008) 480-492
15. Charkes N.D., Maurer A.H., Siegel J.A., et al. MR imaging in thyroid disorders: correlation of signal intensity with Graves disease activity. Radiology 164 (1987) 491-494
16. Takashima S., Fukuda H., Tomiyama N., et al. Hashimoto thyroiditis: correlation of MR imaging signal intensity with histopathologic findings and thyroid function test results. Radiology 197 (1995) 213-219
17. Mountz J.M., Glazer G.M., Dmuchowski C., et al. MR imaging of the thyroid: comparison with scintigraphy in the normal and diseased gland. J Comput Assist Tomogr 11 (1987) 612-619
18. Tezuka M., Murata Y., Ishida R., et al. MR imaging of the thyroid: correlation between apparent diffusion coefficient and thyroid gland scintigraphy. J Magn Reson Imag 17 (2003) 163-169
19. Abdel Razek A.K., Sadek A., Ombar O., et al. Role of apparent diffusion coefficient value in differentiation between malignant and benign solitary thyroid nodule. AJNR Am J Neuroradiol 29 (2008) 563-568
20. Schueller-Weidekamm C., Kaserer K., Schueller G., et al. Can quantitative diffusion-weighted MR imaging differentiate benign and malignant cold thyroid nodules? Initial results in 25 patients. AJNR Am J Neuroradiol 30 (2009) 417-422
21. Bozgeyik Z., Coskun S., Dagli A.F., et al. Diffusion-weighted MR imaging of thyroid nodules. Neuroradiology 51 (2009) 193-198
22. Patel R., Carlos R., Midia M., et al. Apparent diffusion coefficient mapping of the Normal parotid gland and parotid Involvement in patients with systemic connective tissue disorders. AJNR Am J Neuroradiol 25 (2004) 16-20
23. Regier M., Ries T., Arndt C., et al. Sjögren's syndrome of the parotid gland: value of diffusion-weighted echo-planar MRI for diagnosis at an early stage based on MR sialography grading in comparison with healthy volunteers. Rofo 181 (2009) 242-248
24. Kawai Y., Sumi M., Kitamori H., et al. Diffusion-weighted MR microimaging of the lacrimal glands in patients with Sjögren's syndrome. AJR Am J Roentgenol 184 (2005) 1320-1325
25. Thoeny H., De Keyzer F., Oyen R., et al. Diffusion-weighted MR imaging of kidneys in healthy volunteers and patients with parenchymal diseases: initial experience. Radiology 235 (2005) 911-917
26. Morosini P., Simonella G., Mancini V., et al. Color Doppler sonography patterns related to histological findings in Graves' disease. Thyroid 8 (1998) 577-582
27. Fountoulakis S., Vartholomatos G., Kolaitis N., et al. Differential expression of Fast system apoptotic molecules in peripheral lymphocytes from patients with Graves' disease and Hashimoto's thyroiditis. Eur J Endocrinol 158 (2008) 853-859
28. Garrity J.A., and Bahn R.S. Perspective pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatment. Am J Ophthalmol 142 (2006) 147-153
29. Jameson J.L., Weetman A.P., and Daag A.S. Disorders of the thyroid gland. In: Fauci A.S., Braunwald E.B., Kasper D.L., et al. (Eds). Harrison's principles of internal medicine. 17th ed. (2008), McGraw-Hill, New York 2224-2247